Which Cosmetic Claims Are Illegal in Korea — and Why

In Korea, the marketing copy on your cosmetic — not just the formula — decides whether the product is legal to sell. Any claim you make falls into one of three buckets: (1) allowed as ordinary cosmetic language, (2) legal only after your product clears the MFDS (식약처) functional-cosmetic review, or (3) prohibited — either because the wording reclassifies your product into a stricter regime (quasi-drug or medical device) or because it constitutes illegal misleading advertising. The third bucket is the dangerous one: it can carry criminal liability, not just a listing takedown.

This is why porting your US or EU marketing copy straight into a Korean listing is a compliance decision, not a translation task. A claim that sits comfortably on a Sephora product page can be an unapproved-quasi-drug problem on Coupang. Below is how the words map to outcomes, and how to sort your own claims before anything goes live.

The three outcomes every cosmetic claim triggers

Every efficacy or safety statement on a Korean cosmetic listing resolves to one of three legal outcomes. Sorting each claim into the right bucket at listing-build time is the whole game.

• Allowed as ordinary cosmetic language. General cleansing, moisturizing, softening, and cosmetic appearance claims are fine as long as they stay within cosmetic bounds and are not medical or therapeutic.
• Conditionally legal — only after MFDS functional-cosmetic review. A defined set of efficacy claims (whitening, wrinkle improvement, UV protection, and similar) is permitted only once the product has passed the functional-cosmetic (기능성화장품) review. Use the claim without the review and it becomes a violation.
• Prohibited or reclassifying. Medical claims push the product out of the cosmetics regime entirely (into quasi-drug or medical-device territory, neither of which you can sell under a cosmetics import path). Unsubstantiated safety claims are treated as misleading advertising and carry criminal exposure.

The Cosmetics Act (화장품법) and its advertising rules are what govern this — you can read the statute text on Korea's official law portal, law.go.kr, and the functional-cosmetic and advertising guidance sits with the Ministry of Food and Drug Safety (MFDS / 식약처).

The efficacy-word trap: when a claim turns your cosmetic into a drug

The most expensive mistake is a medical or therapeutic claim, because it doesn't just get flagged — it reclassifies your product out of the cosmetics category. Words like "treats acne," "heals," "anti-inflammatory," "antibacterial," or "prevents" a named condition assert a medical effect. Under Korean law, a product that claims to treat, cure, or prevent disease is not a cosmetic. It is a quasi-drug (의약외품) or, in device-adjacent categories, a medical device (의료기기) — categories with their own approval regimes that you cannot enter through a cosmetics import path.

That means the claim doesn't only require different paperwork. It puts your product in a bucket your entire import and selling setup was never built for. A cosmetics-track shipment carrying quasi-drug marketing copy is, in effect, an unapproved quasi-drug — a far more serious problem than a listing edit.

The practical failure mode is subtle. A US acne serum sold as "clears breakouts and calms inflammation" reads as routine skincare copy in the West. In Korea, "calms inflammation" is an anti-inflammatory claim and "clears breakouts" edges toward treating a skin condition — both medical framings. The formula might be identical to a compliant Korean product; only the words differ. This is the same principle behind why a whitening or anti-wrinkle claim reclassifies your cosmetic as a functional cosmetic — the claim, not the chemistry, sets the regime.

The safety-word trap: "non-toxic" can be a criminal violation

Here is the counterintuitive part Western brands miss most often: unsubstantiated safety words are treated more harshly than many efficacy claims. Terms like "non-toxic," "harmless to the body," "eco-friendly," "chemical-free," or "safety verified" — asserted without proof — are classified as misleading or exaggerated advertising under Korea's cosmetics advertising rules. This carries criminal exposure, not merely an administrative takedown.

The trap is that these words feel harmless. A brand assumes that because its product genuinely is safe, saying "non-toxic" is just honest marketing. But Korean regulators treat the claim as inherently misleading: it implies other comparable products are toxic, and it asserts a safety status the brand usually cannot substantiate to the required standard. The violation is in the claim's structure, not the product's actual safety. You can be selling a perfectly benign moisturizer and still be committing an advertising offense by calling it "harmless."

The same logic catches comparative and absolute claims: "the safest," "clinically proven safe," "no side effects," and "guaranteed" language. Strip these before they reach a Korean listing. If you want to communicate safety, do it through what you can actually document — specific test results, certifications your product genuinely holds, and factual ingredient information — rather than a blanket adjective.

Functional-cosmetic trigger words: legal only after MFDS review

A distinct middle category is claims that are perfectly legal — but only after your product clears the MFDS functional-cosmetic (기능성화장품) review. These aren't banned. They're gated. Using the claim before you have cleared the review is the violation.

The efficacy categories that trigger this include:

• Whitening / brightening of skin tone
• Wrinkle improvement and anti-aging efficacy
• UV protection (SPF / sunscreen claims)
• Hair-loss relief and related hair/scalp efficacy
• Other defined efficacy claims MFDS lists under the functional regime

The distinction from the efficacy-word trap above is that these are recognized, reviewable claims. Korea has a defined pathway to make them legally. What you cannot do is print "brightens and reduces wrinkles" on a listing that never went through review — that turns a legitimate, reviewable claim into an unapproved one. If your product genuinely has this efficacy, the correct move is to plan the review into your launch timeline, not to quietly drop the claim into the copy and hope. We cover the mechanics of that review in how a whitening or SPF claim triggers functional-cosmetic review.

Why "just translate the marketing" is not a safe strategy

The compliant Korean wording is what governs — not your English source copy. Korea requires mandatory label content (full ingredient list, cautions, and any functional-review or approval references where applicable) to appear in Korean, and the listing and label language is judged on its Korean meaning. A literal translation of a US tagline can produce a claim that is illegal in Korean even when the English felt fine.

This is why claim decisions belong at listing-build time as a compliance question, mapped word by word to the correct regime. Translating first and checking compliance later inverts the order: you end up with polished Korean copy that has to be torn apart. The label and the listing should be built from a compliance-approved claim set, not the other way around. The mandatory Korean disclosure content itself is a separate discipline — see how Korean-language labeling and disclosure requirements work for what has to appear on the label regardless of your marketing claims.

Who actually carries the liability in Korea

The final point Western brands underestimate: a Korean-registered responsible distributor (책임판매업자) is legally accountable for the claims and labeling on the product. That means the entity operating in Korea — not just your overseas brand team — carries compliance liability for whatever the listing says. If your Korean listing calls a product "non-toxic" or claims it "heals acne," the responsible distributor is the party the regulator holds answerable.

This has a direct operational consequence: the party responsible for the claim needs sign-off on the claim. You cannot treat Korean listing copy as a downstream marketing task disconnected from the entity that bears the legal risk. In practice this splits approval and liability in a specific way — the brand supplies and approves the intent of the claim, but the Korea-side responsible party carries the regulatory exposure and therefore has the final compliance veto. We break down how that approval-and-liability split works across market-entry models, and how the cosmetics Importer of Record and Responsible Person roles are scoped and priced.

Common questions

Is "anti-aging" banned in Korea? Not as a blanket rule. It depends on the specific efficacy the phrase asserts. A general cosmetic appearance claim can be allowed, a "wrinkle improvement" efficacy claim requires MFDS functional-cosmetic review, and a medical or disease-related framing can reclassify the product entirely. The exact wording decides.

Can I say my cosmetic is "non-toxic" if it genuinely is? Generally no. Under Korea's cosmetics advertising rules, unsubstantiated safety claims like "non-toxic," "harmless," and "eco-friendly" are treated as misleading advertising and carry criminal exposure regardless of whether the product is actually safe. The violation is in the claim itself.

What happens if a claim reclassifies my product as a quasi-drug? You can no longer sell it under a cosmetics import path. Quasi-drugs (의약외품) and medical devices (의료기기) have separate approval regimes. A product carrying medical claims but imported and listed as a cosmetic is effectively an unapproved quasi-drug — a serious violation, not a listing edit.

Where can I verify these rules myself? The governing law is the Cosmetics Act (화장품법), available on Korea's official law portal at law.go.kr, and the functional-cosmetic and advertising guidance is published by the Ministry of Food and Drug Safety (MFDS / 식약처). Always check the current statute text and MFDS guidance rather than relying on secondhand summaries.